AI assistant
ORMAT TECHNOLOGIES, INC. — Director's Dealing 2025
Aug 26, 2025
6968_rns_2025-08-26_0a48fde1-9e1a-47fc-bd20-ece8b2d434a2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4 UNITED STATES SECURITIES AND EXCHANGE
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
Washington, D.C. 20549
COMMISSION
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| Check this box to indicate that a transaction was made pursuant to a purchase or sale of equity securities of affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
contract, instruction or written plan for the the issuer that is intended to satisfy the |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Name and Address of Reporting Person* Ginzburg |
Assi | 2. Issuer Name and Ticker or Trading Symbol ORMAT TECHNOLOGIES, INC. [ ORA ] |
5. Relationship of Reporting Person(s) to Issuer (Check all applicable) |
|||||||||||||
| (Last) (First) (Middle) C/O ORMAT TECHNOLOGIES, INC. 6884 SIERRA CENTER PARKWAY |
3. Date of Earliest Transaction (Month/Day/Year) | 08/22/2025 | Director Officer (give title X below) below) Chief Financial Officer |
10% Owner Other (specify |
||||||||||||
| (Street) RENO NV 89511 |
4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person |
||||||||||||||
| (City) | (State) | (Zip) | ||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||||||||
| 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) |
2A. Deemed Execution Date, if any (Month/Day/Year) |
3. Transaction Code (Instr. 8) |
4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership |
||||||||||
| V | Amount | (A) or (D) |
Price | Reported Transaction(s) (Instr. 3 and 4) |
(Instr. 4) | |||||||||||
| Common Stock | 08/22/2025 | M(1)(2) | 25,524 | A | \$68.34 | 59,349 | D | |||||||||
| Common Stock 08/22/2025 |
D(1)(2) | 18,458 | D | \$94.71 | 40,891 | D | ||||||||||
| Common Stock 08/22/2025 |
S(1)(2) | 7,066 | D | \$94.71 | 33,825 | D |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) |
2. Conversio n or Exercise Price of Derivative Security |
3. Transaction Date (Month/Day/Yea r) |
3A. Deemed Execution Date, if any (Month/Day/Yea r) |
4. Transacti on Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Yea r) |
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
8. Price of Derivat ive Securit y |
9. Number of derivative Securities Beneficial |
10. Ownershi p Form: Direct (D) or Indirect (I) (Instr. |
11. Nature of Indirect Beneficial Ownershi p (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercis able |
Expiratio n Date |
Title | Amount or Number of Shares |
(Instr. 5) |
ly Owned Following Reported Transacti on(s) (Instr. 4) |
4) | |||||
| Stock Appreciation Rights (SARs) |
\$68.34 | 08/22/2025 | M | 25,524 | 05/12/2 020 |
05/12/20 26 |
Common Stock |
25,524 | \$0 | 0 | D | ||||
Explanation of Responses:
-
Represents the exercise of Stock Appreciation Rights ("SARs") expiring on May 12, 2026, for which the reporting person exercised all 25,524 shares, disposed of 18,458 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 7,066 shares acquired upon exercise in the open market on August 22, 2025.
-
Each SAR represents the right to receive shares of ORA common stock with a value equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
Remarks:
/s/ Jessica Woelfel – as attorney-in-fact 08/25/2025
** Signature of Reporting Person Date